ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,967.84
-0.22%
US Tech 100
21,102.40
-0.27%
Dow Jones
42,206.82
0.08%
Brent Oil
76.125
0.00%
Bitcoin
101,496.77
-1.76%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cue Biopharma Inc (CUE) Quote

Cue Biopharma Inc

Cue Biopharma Inc (CUE)

Cue Energy Resources Limited
0.7007
0.0452
(6.90%)
Closed June 21 4:00PM
15 min delayed - Upgrade to Realtime
0.7007
0.00
(0.00%)
After Hours: 6:48PM
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.7007
Bid
0.6303
Ask
0.7007
Volume
1,080,713
0.6195 Day's Range 0.7358
0.45 52 Week Range 1.9891
Market Cap
52.798M
Previous Close
0.6555
Open
0.69
Last Trade
2
@
0.7007
Last Trade Time
Financial Volume
$ 714,342
VWAP
0.660992
Average Volume (3m)
179,662
Shares Outstanding
75,349,881
Dividend Yield
-
PE Ratio
-1.28
Earnings Per Share (EPS)
-0.54
Revenue
9.29M
Net Profit
-40.77M

About Cue Biopharma Inc

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant ... Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.cuebiopharma.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Cue Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CUE. The last closing price for Cue Biopharma was $0.66. Over the last year, Cue Biopharma shares have traded in a share price range of $ 0.45 to $ 1.9891.

Cue Biopharma currently has 75,349,881 shares outstanding. The market capitalization of Cue Biopharma is $49.39 million. Cue Biopharma has a price to earnings ratio (PE ratio) of -1.28.

Ask ADVFN Intelligence (AI)

CUE Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
June 10 2025
CUE (6.90%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 12 2025
CUE (6.90%)

Form 8-K - Current report
Edgar (US Regulatory)
May 12 2025
CUE (6.90%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 25 2025
CUE (6.90%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 25 2025
CUE (6.90%)

Form 8-K - Current report
Edgar (US Regulatory)
April 15 2025
CUE (6.90%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.06510.22494887530.63570.70070.54062018820.62708347CS
40.01071.550724637680.690.70070.54061573320.6374625CS
12-0.3093-30.62376237621.011.050.54061796620.71656147CS
26-0.3148-30.99950763171.01551.750.54062148551.05437122CS
52-0.6493-48.09629629631.351.98910.454137101.11497439CS
156-2.2293-76.08532423212.935.120.453207582.15354497CS
260-23.3993-97.092531120324.126.440.453309376.21505864CS

CUE - Frequently Asked Questions (FAQ)

What is the current Cue Biopharma share price?
The current share price of Cue Biopharma is $ 0.7007
How many Cue Biopharma shares are in issue?
Cue Biopharma has 75,349,881 shares in issue
What is the market cap of Cue Biopharma?
The market capitalisation of Cue Biopharma is USD 49.39M
What is the 1 year trading range for Cue Biopharma share price?
Cue Biopharma has traded in the range of $ 0.45 to $ 1.9891 during the past year
What is the PE ratio of Cue Biopharma?
The price to earnings ratio of Cue Biopharma is -1.28
What is the cash to sales ratio of Cue Biopharma?
The cash to sales ratio of Cue Biopharma is 5.6
What is the reporting currency for Cue Biopharma?
Cue Biopharma reports financial results in USD
What is the latest annual turnover for Cue Biopharma?
The latest annual turnover of Cue Biopharma is USD 9.29M
What is the latest annual profit for Cue Biopharma?
The latest annual profit of Cue Biopharma is USD -40.77M
What is the registered address of Cue Biopharma?
The registered address for Cue Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cue Biopharma website address?
The website address for Cue Biopharma is www.cuebiopharma.com
Which industry sector does Cue Biopharma operate in?
Cue Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXTTNext Technology Holding Inc
$ 3.44
(158.65%)
13.84M
WHLRWheeler Real Estate Investment Trust Inc
$ 7.15
(109.06%)
52.35M
CTORCitius Oncology Inc
$ 2.63
(69.68%)
20.77M
LUCYInnovative Eyewear Inc
$ 3.52
(54.39%)
111.21M
LGCLLucas GC Ltd
$ 1.0407
(53.16%)
11.17M
NWGLNature Wood Group Ltd
$ 1.71
(-69.63%)
3.99M
ICUSeaStar Medical Holding Corporation
$ 0.351
(-64.05%)
21.9M
MBRXMoleculin Biotech Inc
$ 0.259999
(-55.40%)
16.84M
RGCRegencell Bioscience Holdings Ltd
$ 37.50
(-40.81%)
2.22M
CGTLCreative Global Technology Holdings Ltd
$ 1.4399
(-36.57%)
6.71M
HCTIHealthcare Triangle Inc
$ 0.0297
(12.08%)
583.72M
DFLIDragonfly Energy Holdings Corporation
$ 0.245
(12.39%)
334.37M
GNLNGreenlane Holdings Inc
$ 0.009
(-13.04%)
262.88M
NVDANVIDIA Corporation
$ 143.85
(-1.12%)
242.95M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.359
(-0.09%)
193.97M

CUE Discussion

View Posts
boston127 boston127 5 months ago
Send URL for the funds loading info.

I also bought today and last week, but am RED because I bought at a higher price.
👍️0
Hawkeye_tt Hawkeye_tt 5 months ago
You can easily see when a Fund is loading for the day.
I backed up the truck in the 50 cent dip area. That was a gift.
GL all.....be patient.

Hawk
👍️0
boston127 boston127 5 months ago
Today's volume was heavier than usual,

trading 1,209,308 shares, versus an average of 459,032 shares per day during the last twelve months. The On Balance Volume indicator (OBV) shows that longer term selling pressure has given way to near term accumulation by traders.
👍️0
boston127 boston127 5 months ago
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic Oscillator is rising, as investors pay higher prices for shares. Good day today. Got back in recently. Will continue adding all the way to $3.
👍️0
boston127 boston127 5 months ago
Thanks. Interesting perspective.

As long as the company is doing well, I can wait and suffer through any dips.
👍️0
Hawkeye_tt Hawkeye_tt 5 months ago
This could be Over $5 right now...IMO. Algos/shorts walked this down for mths.
LT looks very good IMO.

Hawk
👍️0
boston127 boston127 5 months ago
Great day on Friday.

Wondering if profit taking will follow suit this week.
👍️0
Hawkeye_tt Hawkeye_tt 6 months ago
2025 should be a very good yr. New Partnerships and more.

Hawk
👍️0
glenn1919 glenn1919 6 months ago
cue.........................https://stockcharts.com/h-sc/ui?s=cue&p=W&b=5&g=0&id=p86431144783
👍️0
Hawkeye_tt Hawkeye_tt 8 months ago
TY for that quick dip/Algo dump op. Took advantage big time.
GL all...

Hawk
👍️0
boston127 boston127 8 months ago
Momentum for CUE is waning,

as measured by a 14-period Slow Stochastic Oscillator. This means that investors are less aggressive in their recent purchases and may even be taking profits in positions bought at lower prices.
👍️0
boston127 boston127 8 months ago
The On Balance Volume indicator (OBV) is bullish.

The slope of the indicator is positive and suggests that buyers are presently more active than sellers.Today's volume was heavier than usual, trading 2,320,021 shares, versus an average of 389,835 shares per day during the last twelve months.
👍️0
boston127 boston127 8 months ago
Momentum for CUE is strongly bullish.

The 14-period Slow Stochastic oscillator is above 80, the level which many analysts call overbought. This means that investors have been actively purchasing shares and driving the price higher.
👍️0
boston127 boston127 8 months ago
I got in on Friday. Everything

about the company is good. Gotta love it. They did not give up much to get that $11M in financing. Will buy on dips. Bought a little more today.
👍️0
Monksdream Monksdream 8 months ago
CUE under $2
👍️0
Hawkeye_tt Hawkeye_tt 9 months ago
Look at that Wkly candle ! Vol fantastic.
LT outlook back on !

Hawk
👍️0
Triple nickle Triple nickle 9 months ago
CUE ready to win 1.02
👍️0
Hawkeye_tt Hawkeye_tt 9 months ago
Strong recovery on news....future looking good here. Buy, hold LT...
Hawk
👍️0
Monksdream Monksdream 12 months ago
CUE new 52 week low
👍️0
Hawkeye_tt Hawkeye_tt 2 years ago
CUE....this story grows quickly. Merck early investor.
Last few wks it has been breaking out.
$5 break next. More Partners want in, on top of Ono.

Hawk
👍️0
conix conix 3 years ago
CUE Insider Buy
Cue Biopharma Aaron G.L. Fletcher Director Buy 735,000 shares @ $4.76 $3,498,600.00 3/31/2022
👍️0

Your Recent History

NASDAQ
CUE
Cue Biopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads